138 related articles for article (PubMed ID: 28961334)
1. Self-Assembly of Novel Thiophene-Based BODIPY Ru
Gupta G; Das A; Panja S; Ryu JY; Lee J; Mandal N; Lee CY
Chemistry; 2017 Dec; 23(68):17199-17203. PubMed ID: 28961334
[TBL] [Abstract][Full Text] [Related]
2. Novel BODIPY-based Ru(II) and Ir(III) metalla-rectangles: cellular localization of compounds and their antiproliferative activities.
Gupta G; Das A; Ghate NB; Kim T; Ryu JY; Lee J; Mandal N; Lee CY
Chem Commun (Camb); 2016 Mar; 52(23):4274-7. PubMed ID: 26961860
[TBL] [Abstract][Full Text] [Related]
3. Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: their anticancer activity and potential applications in cellular imaging.
Paitandi RP; Sharma V; Singh VD; Dwivedi BK; Mobin SM; Pandey DS
Dalton Trans; 2018 Dec; 47(48):17500-17514. PubMed ID: 30507985
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
[TBL] [Abstract][Full Text] [Related]
5. BODIPY-phosphane as a versatile tool for easy access to new metal-based theranostics.
Tasan S; Zava O; Bertrand B; Bernhard C; Goze C; Picquet M; Le Gendre P; Harvey P; Denat F; Casini A; Bodio E
Dalton Trans; 2013 May; 42(17):6102-9. PubMed ID: 23232925
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of opened arene ruthenium metalla-assemblies.
Barry NP; Zava O; Furrer J; Dyson PJ; Therrien B
Dalton Trans; 2010 Jun; 39(22):5272-7. PubMed ID: 20442944
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents.
Camm KD; El-Sokkary A; Gott AL; Stockley PG; Belyaeva T; McGowan PC
Dalton Trans; 2009 Dec; (48):10914-25. PubMed ID: 20023922
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium- and osmium-arene-based paullones bearing a TEMPO free-radical unit as potential anticancer drugs.
Arion VB; Dobrov A; Göschl S; Jakupec MA; Keppler BK; Rapta P
Chem Commun (Camb); 2012 Sep; 48(68):8559-61. PubMed ID: 22797078
[TBL] [Abstract][Full Text] [Related]
9. Gold(i)-BODIPY-imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents.
Trommenschlager A; Chotard F; Bertrand B; Amor S; Dondaine L; Picquet M; Richard P; Bettaïeb A; Le Gendre P; Paul C; Goze C; Bodio E
Dalton Trans; 2017 Jun; 46(25):8051-8056. PubMed ID: 28594007
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes.
Brustolin L; Nardon C; Pettenuzzo N; Zuin Fantoni N; Quarta S; Chiara F; Gambalunga A; Trevisan A; Marchiò L; Pontisso P; Fregona D
Dalton Trans; 2018 Nov; 47(43):15477-15486. PubMed ID: 30334060
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
[TBL] [Abstract][Full Text] [Related]
12. Coordination-driven self-assembly of ruthenium-based molecular-rectangles: synthesis, characterization, photo-physical and anticancer potency studies.
Vajpayee V; Song YH; Jung YJ; Kang SC; Kim H; Kim IS; Wang M; Cook TR; Stang PJ; Chi KW
Dalton Trans; 2012 Mar; 41(10):3046-52. PubMed ID: 22278716
[TBL] [Abstract][Full Text] [Related]
13. BODIPY-based Ru(II) and Ir(III) organometallic complexes of avobenzone, a sunscreen material: Potent anticancer agents.
Gupta G; Cherukommu S; Srinivas G; Lee SW; Mun SH; Jung J; Nagesh N; Lee CY
J Inorg Biochem; 2018 Dec; 189():17-29. PubMed ID: 30153544
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity, cellular uptake, and subcellular localization of a nitrogen oxide and aminopropyl-β-lactose derivative ruthenium complex used as nitric oxide delivery agent.
Dos Santos JS; Ramos LC; Ferreira LP; Campo VL; de Rezende LCD; da Silva Emery F; Santana da Silva R
Nitric Oxide; 2019 May; 86():38-47. PubMed ID: 30790696
[TBL] [Abstract][Full Text] [Related]
15. A novel ruthenium(III) complex with a tridentate dianionic P,O,O-ligand showing high cytotoxic activity.
van Rijn JA; Marqués-Gallego P; Reedijk J; Lutz M; Spek AL; Bouwman E
Dalton Trans; 2009 Dec; (48):10727-30. PubMed ID: 20023901
[TBL] [Abstract][Full Text] [Related]
16. Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives.
Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
Dalton Trans; 2012 Oct; 41(38):11608-18. PubMed ID: 22903512
[TBL] [Abstract][Full Text] [Related]
17. Lipophilicity-dependent ruthenium N-heterocyclic carbene complexes as potential anticancer agents.
Lv G; Guo L; Qiu L; Yang H; Wang T; Liu H; Lin J
Dalton Trans; 2015 Apr; 44(16):7324-31. PubMed ID: 25797411
[TBL] [Abstract][Full Text] [Related]
18. Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action.
Novohradsky V; Yellol J; Stuchlikova O; Santana MD; Kostrhunova H; Yellol G; Kasparkova J; Bautista D; Ruiz J; Brabec V
Chemistry; 2017 Nov; 23(61):15294-15299. PubMed ID: 28922506
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of osmium metalla-rectangles.
Barry NP; Edafe F; Dyson PJ; Therrien B
Dalton Trans; 2010 Mar; 39(11):2816-20. PubMed ID: 20200707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
